Health-related quality of life with sacituzumab govitecan in HR+/HER2- metastatic breast cancer in the phase III TROPiCS-02 trial

  1. Rugo, H.S.
  2. Schmid, P.
  3. Tolaney, S.M.
  4. Dalenc, F.
  5. Marmé, F.
  6. Shi, L.
  7. Verret, W.
  8. Shah, A.
  9. Gharaibeh, M.
  10. Bardia, A.
  11. Cortes, J.
Aldizkaria:
Oncologist

ISSN: 1549-490X,  1083-7159

Argitalpen urtea: 2024

Alea: 29

Zenbakia: 9

Orrialdeak: 768-779

Mota: Artikulua

DOI: 10.1093/ONCOLO/OYAE088 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus